InterCure Advances Global Push With Botanico Acquisition Tranche and U.S. Strategy Review
Claim 55% Off TipRanks
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
Intercure ( (IL:INCR) ) has issued an update.
On June 15, 2026, InterCure announced it had completed the first tranche, equal to 50%, of its acquisition of Israeli cannabis technology and brand company Botanico, also known as ISHI, issuing 2,471,061 ordinary shares as part of the initial closing. The deal gives InterCure exclusive rights to a wide portfolio of award-winning U.S. cannabis genetics, proprietary strains, premium brands and advanced AI-driven, automated production technologies, and deepens its alliances with American operators such as The Flowery.
The company said the Botanico transaction expands its international medical cannabis platform at a time when it is reporting its first meaningful revenues from Germany’s rapidly growing market, where it has installed a local management and sales team and is preparing multiple product launches in the second half of the year. Following the recent U.S. federal decision to move certain state-licensed medical cannabis from Schedule I to Schedule III, InterCure has also begun a strategic review focused solely on opportunities in regulated U.S. medical cannabis markets, underscoring its ambition to build a leading global presence across tightly regulated jurisdictions.
More about Intercure
InterCure Ltd., which operates as Canndoc, is a leading, profitable medical cannabis company based in Israel and listed on Nasdaq and the Tel Aviv Stock Exchange. Through its wholly owned subsidiary Canndoc, it is Israel’s largest licensed cannabis producer, offering GMP-certified, pharmaceutical-grade products and leveraging a vertically integrated seed-to-sale model and international partnerships to target fast-growing cannabis markets outside North America.
Average Trading Volume: 61,369
Technical Sentiment Signal: Sell
Current Market Cap: ILs143.7M
For an in-depth examination of INCR stock, go to TipRanks’ Overview page.
